Morag Nelson Australian and New Zealand Obesity Society Annual Scientific Conference 2024

Abstracts this author is presenting:

• Glucagon and GLP-1 receptor dual agonist survodutide improved liver histology in people with MASH and fibrosis: Results from a randomized, double-blind, placebo-controlled phase 2 trial — Poster Session Day 2